Hormone release patterns, clearance and receptor regulation
- Concept
- For completeness
Hormones come in pulses and daily rhythms, are cleared at set rates, and target cells turn their receptors up or down to match.
Also called: Pulsatile secretion, Metabolic clearance rate, Receptor down-regulation
What it is
A hormone's effect depends on more than how much is secreted. Many hormones are released in pulses or on a daily rhythm, so one blood sample can mislead. The plasma level at any moment balances secretion against clearance, which sets the half-life. Target cells then adjust their sensitivity by changing the number and coupling of receptors: sustained exposure turns them down, while a lack of hormone or a priming hormone turns them up.
Key facts
- Patterns: pulsatile (GnRH, LH, insulin), circadian (cortisol, ACTH, melatonin), sleep-linked (GH, prolactin), monthly (ovarian cycle), life-stage (puberty, menopause).
- Onset and duration differ: catecholamines act in seconds; peptides in minutes; steroid and thyroid hormones need hours to days because they change gene expression.
- Clearance routes: liver metabolism, kidney excretion, uptake and breakdown by target tissues, and enzymes in blood and tissue.
- Only the free fraction acts and is cleared; the bound fraction is a reservoir that buffers sudden changes.
Equations
- MCR
- volume of plasma cleared of the hormone per minute (mL/min)
At steady state removal equals secretion, so secretion rate = MCR × plasma concentration.
- Vd
- volume of distribution
- CL
- clearance
A large binding pool (high V_d) or low clearance (liver or kidney failure) lengthens half-life.
Regulation
- −Sustained high hormone (homologous down-regulation): Receptors are phosphorylated, uncoupled (β-arrestin), internalized and made in smaller numbers.
- −Another signal (heterologous desensitization): A kinase activated by one hormone dampens receptors of another.
- +Hormone lack (denervation, blocker): Receptor numbers rise: supersensitivity and rebound when a blocker is stopped.
- +Priming hormone: Estrogen raises progesterone and oxytocin receptors; thyroid hormone raises cardiac β₁ receptors.
Clinical notes
- Continuous GnRH agonists are used to suppress sex steroids in prostate cancer, endometriosis and central precocious puberty; a pulsatile pump instead restores fertility in hypothalamic deficiency.
- Hyperinsulinemia of obesity down-regulates insulin receptors and post-receptor signalling, adding to insulin resistance.
- Liver failure slows clearance of estrogen and aldosterone; kidney failure slows clearance of insulin and PTH fragments.
- Abrupt withdrawal of a β-blocker after long use can cause rebound tachycardia from up-regulated β receptors.
Test yourself
Think of the answer, then tap the question to see it.
Why does a continuously given GnRH agonist lower testosterone after a short initial rise?
The first exposure stimulates LH release (flare), but constant occupancy desensitizes and internalizes pituitary GnRH receptors, so LH, FSH and testosterone fall.
Why is a single random GH level a poor test for acromegaly or GH deficiency?
GH is released in short bursts, mostly in deep sleep, with very low levels between them; IGF-1 or suppression and stimulation tests integrate secretion better.
Why does T4 have a much longer half-life than insulin?
Over 99% of T4 is bound to plasma proteins (TBG, transthyretin, albumin), shielding it from clearance; insulin is unbound and cleared rapidly by liver and kidney.
Why can adrenal insufficiency follow the end of long-term glucocorticoid treatment?
Exogenous glucocorticoid suppressed CRH and ACTH for months, the adrenal cortex atrophied and the axis needs months to recover.
Connections
In Biochemistry1
In Pharmacology1
Educational physiology content; not a diagnostic or treatment guide and no substitute for a health professional's advice. Values are approximate references. No doses are given.
Sources: Hormones | Hormone Function | MedlinePlus (MedlinePlus, US National Library of Medicine, 2026); Cortisol Test: MedlinePlus Medical Test (MedlinePlus, US National Library of Medicine, 2026); Hypercortisolism (Cushing Syndrome) (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.